Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin

Baggott, Rhiannon R., Alfranca, Arantzazu, López-Maderuelo, Dolores, Mohamed, Tamer M.A., Escolano, Amelia, Oller, Jorge, Ornes, Beatriz C., Kurusamy, Sathishkumar, Rowther, Farjana B., Brown, James E., Oceandy, Delvac, Cartwright, Elizabeth J., Wang, Weiguang, Gómez-del Arco, Pablo, Martínez-Martínez, Sara, Neyses, Ludwig, Redondo, Juan Miguel and Armesilla, Angel L. (2014). Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin. Arteriosclerosis, Thrombosis, and Vascular biology, 34 (10), pp. 2310-2320.


Approach and Results - Using in vitro and in vivo assays, we here demonstrate that the interaction between PMCA4 and calcineurin in VEGF-stimulated endothelial cells leads to downregulation of the calcineurin/NFAT pathway and to a significant reduction in the subsequent expression of the NFAT-dependent, VEGF-activated, proangiogenic genes RCAN1.4 and Cox-2. PMCA4-dependent inhibition of calcineurin signaling translates into a reduction in endothelial cell motility and blood vessel formation that ultimately impairs in vivo angiogenesis by VEGF. Objective - Vascular endothelial growth factor (VEGF) has been identified as a crucial regulator of physiological and pathological angiogenesis. Among the intracellular signaling pathways triggered by VEGF, activation of the calcineurin/ nuclear factor of activated T cells (NFAT) signaling axis has emerged as a critical mediator of angiogenic processes. We and others previously reported a novel role for the plasma membrane calcium ATPase (PMCA) as an endogenous inhibitor of the calcineurin/NFAT pathway, via interaction with calcineurin, in cardiomyocytes and breast cancer cells. However, the functional significance of the PMCA/calcineurin interaction in endothelial pathophysiology has not been addressed thus far. Conclusions - Given the importance of the calcineurin/NFAT pathway in the regulation of pathological angiogenesis, targeted modulation of PMCA4 functionality might open novel therapeutic avenues to promote or attenuate new vessel formation in diseases that occur with angiogenesis.

Publication DOI:
Divisions: Life & Health Sciences > Biosciences
Life & Health Sciences
Life & Health Sciences > Applied Health Research Group
Life & Health Sciences > Biomedical Sciences research group
Additional Information: © 2014 American Heart Association, Inc.
Uncontrolled Keywords: angiogenesis effect,calcineurin,calcium,nuclear factors of activated T cells,plasma membrane calcium-transporting ATPase,Cardiology and Cardiovascular Medicine,Medicine(all)
Full Text Link:
Related URLs:
Published Date: 2014-10
Authors: Baggott, Rhiannon R.
Alfranca, Arantzazu
López-Maderuelo, Dolores
Mohamed, Tamer M.A.
Escolano, Amelia
Oller, Jorge
Ornes, Beatriz C.
Kurusamy, Sathishkumar
Rowther, Farjana B.
Brown, James E.
Oceandy, Delvac
Cartwright, Elizabeth J.
Wang, Weiguang
Gómez-del Arco, Pablo
Martínez-Martínez, Sara
Neyses, Ludwig
Redondo, Juan Miguel
Armesilla, Angel L.


Item under embargo

Export / Share Citation


Additional statistics for this record